Try Alerts Free   |   Login

Celsion Financials and Smart Investor 13F Alerts

CLSN Sector: Health Care, Pharmaceutical Preparations

Data imported from SEC filings and provided as-is without any warranty. Check Celsion Corp filings before making any investment decision.

CLSN stock chart compared to Revenue:
Get email alerts for new filings: We will never share your email address. By submitting your email, you agree to our Terms of Service and Privacy Policy.

CLSN Income Statement

Revenue, Net:125000
Research and Development Expense:2990861
Total Operating Expenses:4891997
Operating Income:-4766997
Net Income (Loss) Attributable to Parent:-5342935
Earnings Per Share, Diluted:-0.18
Earnings Per Share, Basic:-0.18
Weighted Average Number of Shares Outstanding, Basic:33232380
Weighted Average Number of Shares Outstanding, Diluted:29887329

CLSN Cash Flow

Depreciation, Depletion and Amortization:190661
Net Cash from Operations:-2948209
Net Cash from Financing Activities:12759747
Payments to Acquire Property, Plant, and Equipment:3602
Net Cash from Investing Activities:7096038
Net Change in Cash and Cash Equivalents:16907576

CLSN Balance Sheet

Cash and Cash Equivalents:22653760
Short-Term Investments:2784002
Total Current Assets:26796060
Property, Plant and Equipment, Net:339200
Total Assets:46722960
Accounts Payable:2402142
Total Short-Term Liabilities:9205745
Total Liabilities:22514798